Princeton, New Jersey; June 1, 2011 - Sandoz today announced the US Food and Drug Administration (FDA) approval and US launch of donepezil hydrochloride (HCL) film-coated tablets and donepezil HCL ...
(HealthDay News) – For patients with dementia with Lewy bodies (DLB), 5 and 10mg/day doses of donepezil are associated with significant improvements in behavioral, cognitive, and global symptoms, ...
July 27, 2010 — The US Food and Drug Administration (FDA) has approved donepezil HCl 23-mg tablets (Aricept; Eisai, Inc and Pfizer, Inc) for the once-daily treatment of moderate to severe Alzheimer's ...
Two-Way Tie for Hypoglycemia, Dementia in Diabetes For patients with dementia with Lewy bodies (DLB), treatment with 5mg/day or 10mg/day donepezil is associated with significant cognitive, behavioral, ...
Woodcliff Lake, NJ, and New York, July 23, 2010 - Eisai Inc. and Pfizer Inc [NYSE: PFE] announced today that the U.S. Food and Drug Administration (FDA) approved a new once-daily, higher-dose Aricept ...
Forest Laboratories and Adamas Pharmaceuticals Enter into Licensing Agreement for the Development an
Forest Laboratories and Adamas Pharmaceuticals Enter into Licensing Agreement for the Development and Commercialization of a Fixed Dosed Combination of Namenda XR® and Donepezil for Alzheimer's ...
Jan. 3, 2006 — The Chinese Food and Drug Administration has approved qiyao capsules for adjunctive use in the treatment of type 2 diabetes; completion of the mutual recognition procedure has allowed ...
NEW YORK & EMERYVILLE, Calif.--(BUSINESS WIRE)--Forest Laboratories, Inc. (NYSE: FRX), an international pharmaceutical company, and Adamas Pharmaceuticals, Inc. announced today that they have entered ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results